SNP-based Prediction of Recurrence Risk in Kidney Stone Patients
1 other identifier
observational
1,300
1 country
1
Brief Summary
The goal of this study is to gain new knowledge about genetic risk factors that may affect the kidney stone recurrence. The study seeks to understand if different forms of genes result in an increased risk of kidney stone recurrence.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2012
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2012
CompletedFirst Submitted
Initial submission to the registry
June 10, 2021
CompletedFirst Posted
Study publicly available on registry
June 23, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2023
CompletedOctober 25, 2022
October 1, 2022
11 years
June 10, 2021
October 23, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Stone-free survival
Time to first stone recurrence from stone-free
From date of stone-free until the date of first stone recurrence (up to 7 years)
Study Arms (1)
Kidney stone former
Interventions
Eligibility Criteria
Kidney stone former who the stone was removed completely
You may qualify if:
- Age 18 or older
- Kidney stone former who the stone was removed completely.
- Ability to give informed consent
You may not qualify if:
- Patient refuses or is unable to give consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- The First Affiliated Hospital of Guangzhou Medical Universitylead
- Xiangya Hospital of Central South Universitycollaborator
- Wuhan University Renmin Hospitalcollaborator
- The Second Affiliated Hospital of Kunming Medical Universitycollaborator
- Tianjin Medical University Second Hospitalcollaborator
- Shenzhen People's Hospitalcollaborator
- 301 Hospitalcollaborator
- Zhongda Hospitalcollaborator
- People's Hospital of Xinjiangcollaborator
- ZhuZhou Central Hospitalcollaborator
- Baoshan No.2 People's Hospitalcollaborator
- Guangdong No.2 People's Hospitalcollaborator
- Dehong People's Hospitalcollaborator
- Second Affiliated Hospital of Guangzhou Medical Universitycollaborator
- Jiangmen Central Hospitalcollaborator
- Huizhou Municipal Central Hospitalcollaborator
- Yongzhou Center Hospitalcollaborator
- Longgang District People's Hospital of Shenzhencollaborator
Study Sites (1)
The First Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong, 510120, China
Biospecimen
Blood was obtained for DNA
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Guohua Zeng, M.D.
The First Affiliated Hospital of Guangzhou Medical University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Vice president
Study Record Dates
First Submitted
June 10, 2021
First Posted
June 23, 2021
Study Start
January 1, 2012
Primary Completion
December 31, 2022
Study Completion
December 31, 2023
Last Updated
October 25, 2022
Record last verified: 2022-10